Eurazeo
Eurazeo SE is a private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, … Read more
Eurazeo (RF) - Total Liabilities
Latest total liabilities as of June 2025: €2.04 Billion EUR
Based on the latest financial reports, Eurazeo (RF) has total liabilities worth €2.04 Billion EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Eurazeo - Total Liabilities Trend (2003–2024)
This chart illustrates how Eurazeo's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Eurazeo Competitors by Total Liabilities
The table below lists competitors of Eurazeo ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Skyward Specialty Insurance Group, Inc. Common Stock
NASDAQ:SKWD
|
USA | $3.63 Billion |
|
OFG Bancorp
NYSE:OFG
|
USA | $11.08 Billion |
|
Asmodee Group AB (publ)
F:2EX
|
Germany | €1.59 Billion |
|
Getac Technology Corp
TW:3005
|
Taiwan | NT$20.84 Billion |
|
Tera Yatirim Menkul Degerler A.S.
IS:TERA
|
Turkey | TL1.80 Billion |
|
Savills plc
PINK:SVLPF
|
USA | $1.33 Billion |
|
Resolute Mining Ltd
AU:RSG
|
Australia | AU$739.10 Million |
|
JDEPY
OTCGREY:JDEPY
|
USA | $12.90 Billion |
Liability Composition Analysis (2003–2024)
This chart breaks down Eurazeo's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.28 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.31 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Eurazeo's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Eurazeo (2003–2024)
The table below shows the annual total liabilities of Eurazeo from 2003 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €1.87 Billion | +32.47% |
| 2023-12-31 | €1.41 Billion | -85.25% |
| 2022-12-31 | €9.57 Billion | +20.69% |
| 2021-12-31 | €7.93 Billion | +2.65% |
| 2020-12-31 | €7.73 Billion | +6.07% |
| 2019-12-31 | €7.29 Billion | +24.68% |
| 2018-12-31 | €5.84 Billion | +4.92% |
| 2017-12-31 | €5.57 Billion | +8.27% |
| 2016-12-31 | €5.14 Billion | +95.79% |
| 2015-12-31 | €2.63 Billion | -70.10% |
| 2014-12-31 | €8.79 Billion | -0.46% |
| 2013-12-31 | €8.83 Billion | -13.50% |
| 2012-12-31 | €10.21 Billion | -4.44% |
| 2011-12-31 | €10.68 Billion | +4.41% |
| 2010-12-31 | €10.23 Billion | -5.20% |
| 2009-12-31 | €10.79 Billion | -3.47% |
| 2008-12-31 | €11.18 Billion | +3.07% |
| 2007-12-31 | €10.85 Billion | +2204.45% |
| 2003-12-31 | €470.68 Million | -- |